Certified by Founder Lodge
Reverb Therapeutics
Canada - Vancouver, British columbia
START UP
1 Disclosed Funding Rounds $21,000,000
0 Participating Investments
-
Founded date
2023
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
We develop bispecific antibodies that exploit the potential of the natural immune system. Our Amplify•R platform amplifies and redirects endogenous cytokine signaling instead of recombinant
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 21 ,2025 | Seed | $21,000,000 |
KdT Ventures
Amplitude Ventures
InBC Investment Corp.
Seido Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
